Stocks
Novo Nordisk (NVO) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 240.6% | 240.6% | 163.0% | 163.0% | 83.4% | 79.6% | |||
| Changes by years, y/y, % | +171pp | 0pp | -78pp | 0pp | -80pp | -6.9% | |||
Novo Nordisk. R&D/CAPEX, %
Novo Nordisk. R&D/CAPEX, changes, pp
Novo Nordisk (NVO) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2025Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 101.3% | 76.5% | 63.6% | 95.5% | 79.6% | |||
| Changes by years, y/y, % | -98pp | -57pp | -67pp | -45pp | ||||
| Changes by quarters, q/q, % | -140pp | -25pp | -13pp | +32pp | ||||
